Cargando…

Linkage of the CHHiP randomised controlled trial with primary care data: a study investigating ways of supplementing cancer trials and improving evidence-based practice

BACKGROUND: Randomised controlled trials (RCTs) are the gold standard for evidence-based practice. However, RCTs can have limitations. For example, translation of findings into practice can be limited by design features, such as inclusion criteria, not accurately reflecting clinical populations. In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lemanska, Agnieszka, Byford, Rachel C., Cruickshank, Clare, Dearnaley, David P., Ferreira, Filipa, Griffin, Clare, Hall, Emma, Hinton, William, de Lusignan, Simon, Sherlock, Julian, Faithfull, Sara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382082/ https://www.ncbi.nlm.nih.gov/pubmed/32711460 http://dx.doi.org/10.1186/s12874-020-01078-9

Ejemplares similares

Linking CHHiP prostate cancer RCT with GP records: A study proposal to investigate the effect of co-morbidities and medications on long-term symptoms and radiotherapy-related toxicity
por: Lemanska, Agnieszka, et al.
Publicado: (2017)

Evaluation of erectile potency and radiation dose to the penile bulb using image guided radiotherapy in the CHHiP trial
por: Murray, Julia, et al.
Publicado: (2019)

Methodology for tissue sample collection within a translational sub-study of the CHHiP trial (CRUK/06/016), a large randomised phase III trial in localised prostate cancer
por: Wilkins, Anna, et al.
Publicado: (2018)

Multi-candidate immunohistochemical markers to assess radiation response and prognosis in prostate cancer: results from the CHHiP trial of radiotherapy fractionation
por: Wilkins, Anna, et al.
Publicado: (2023)

Forward- and Inverse-Planned Intensity-Modulated Radiotherapy in the CHHiP Trial: A Comparison of Dosimetry and Normal Tissue Toxicity
por: Naismith, O.F., et al.
Publicado: (2019)

Impact of Hypofractionated Radiotherapy on Patient-reported Outcomes in Prostate Cancer: Results up to 5 yr in the CHHiP trial (CRUK/06/016)
por: Staffurth, John N., et al.
Publicado: (2021)

Nonrandomized Comparison of Efficacy and Side Effects of Bicalutamide Compared With Luteinizing Hormone-Releasing Hormone (LHRH) Analogs in Combination With Radiation Therapy in the CHHiP Trial
por: Tree, Alison, et al.
Publicado: (2022)

Estimates of Alpha/Beta (α/β) Ratios for Individual Late Rectal Toxicity Endpoints: An Analysis of the CHHiP Trial
por: Brand, Douglas H., et al.
Publicado: (2021)

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
por: Dearnaley, David, et al.
Publicado: (2016)

Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
por: Wilkins, Anna, et al.
Publicado: (2015)

Symptom clusters for revising scale membership in the analysis of prostate cancer patient reported outcome measures: a secondary data analysis of the Medical Research Council RT01 trial (ISCRTN47772397)
por: Lemanska, Agnieszka, et al.
Publicado: (2017)

BMI and HbA1c are metabolic markers for pancreatic cancer: Matched case-control study using a UK primary care database
por: Lemanska, Agnieszka, et al.
Publicado: (2022)

Randomised controlled trial to investigate the effectiveness of the symptom management after radiotherapy (SMaRT) group intervention to ameliorate lower urinary tract symptoms in men treated for prostate cancer
por: Faithfull, Sara, et al.
Publicado: (2021)

Older Age, Early Symptoms and Physical Function are Associated with the Severity of Late Symptom Clusters for Men Undergoing Radiotherapy for Prostate Cancer
por: Lemanska, A., et al.
Publicado: (2018)

Community pharmacy lifestyle intervention to increase physical activity and improve cardiovascular health of men with prostate cancer: a phase II feasibility study
por: Lemanska, Agnieszka, et al.
Publicado: (2019)

The Siconolfi step test: a valid and reliable assessment of cardiopulmonary fitness in older men with prostate cancer
por: Lemanska, Agnieszka, et al.
Publicado: (2019)

Mortality from angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers in people infected with COVID-19: a cohort study of 3.7 million people
por: Dambha-Miller, Hajira, et al.
Publicado: (2022)

Using a Bayesian approach with reverse philosophy to design clinical trials in rare diseases
por: Billingham, Lucinda, et al.
Publicado: (2013)

A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer
por: Murray, Julia, et al.
Publicado: (2020)

Patient activation and patient-reported outcomes of men from a community pharmacy lifestyle intervention after prostate cancer treatment
por: Lemanska, Agnieszka, et al.
Publicado: (2021)

PIVOTALboost: A phase III randomised controlled trial of prostate and pelvis versus prostate alone radiotherapy with or without prostate boost (CRUK/16/018)
por: Syndikus, Isabel, et al.
Publicado: (2020)

Does Real World Use of Liraglutide Match its Use in the LEADER Cardiovascular Outcome Trial? Study Protocol
por: Hinton, William, et al.
Publicado: (2018)

Sodium–glucose co‐transporter‐2 inhibitor cardiovascular outcome trials and generalizability to English primary care
por: Hinton, W., et al.
Publicado: (2020)

Household presentation of acute gastroenteritis in a primary care sentinel network: retrospective database studies
por: de Lusignan, Simon, et al.
Publicado: (2020)

Ki67 Is an Independent Predictor of Recurrence in the Largest Randomized Trial of 3 Radiation Fractionation Schedules in Localized Prostate Cancer
por: Wilkins, Anna C., et al.
Publicado: (2018)

Real‐world prevalence of the inclusion criteria for the LEADER trial: Data from a national general practice network
por: Hinton, William, et al.
Publicado: (2019)

How Generalizable Are Cardiovascular Outcome Trials of Sodium-Glucose Co-Transporter-2 Inhibitors? A National Database Study: Study Protocol
por: Hinton, William, et al.
Publicado: (2019)

Co-administration of routine paediatric vaccines in England often deviates from the immunisation schedule
por: Bauwens, Jorgen, et al.
Publicado: (2021)

Adherence to the paediatric immunisation schedule in England
por: Bauwens, Jorgen, et al.
Publicado: (2021)

Household presentation of influenza and acute respiratory illnesses to a primary care sentinel network: retrospective database studies (2013–2018)
por: de Lusignan, Simon, et al.
Publicado: (2020)

Using record linkage to monitor equity and variation in screening programmes
por: O’Reilly, Dermot, et al.
Publicado: (2012)

Establishing a controlled hookworm human infection (CHHI) model for Africa: A report from the stakeholders meeting held in Lambaréné, Gabon, November 10–11, 2019
por: Alabi, Ayodele, et al.
Publicado: (2021)

The impact of primary care supported shielding on the risk of mortality in people vulnerable to COVID-19: English sentinel network matched cohort study
por: Zarif, Azmaeen, et al.
Publicado: (2021)

Evaluation of nurse-led follow up for patients undergoing pelvic radiotherapy
por: Faithfull, S, et al.
Publicado: (2001)

A Randomised Controlled Trial of Ice to Reduce the Pain of Immunisation—The ICE Trial
por: Ediriweera, Yashodha, et al.
Publicado: (2021)

Mental Health Presentations Across Health Care Settings During the First 9 Months of the COVID-19 Pandemic in England: Retrospective Observational Study
por: Smith, Gillian E, et al.
Publicado: (2022)

Atrial fibrillation dashboard evaluation using the think aloud protocol
por: de Lusignan, Simon, et al.
Publicado: (2020)

Hypofractionation trials and radiobiology of prostate cancer
por: Gulliford, Sarah, et al.
Publicado: (2017)

Drug trials under way
por: Klein, Alice
Publicado: (2020)

Observation versus screening spinal MRI and pre-emptive treatment for spinal cord compression in patients with castration-resistant prostate cancer and spinal metastases in the UK (PROMPTS): an open-label, randomised, controlled, phase 3 trial
por: Dearnaley, David, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ps2kmmqkdcdk8gf3bkijq83up7